Medicines Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies By Helena Musk / May 18, 2022
Medicines Meitheal Pharmaceuticals Announces Membership in The Association for Accessible Medicines By Helena Musk / May 5, 2022
Medicines Loki Therapeutics Announces Publication in Science Translational Medicine Demonstrating Potential of AWAKE-LM-TT as a Treatment for Pancreatic Cancer By Helena Musk / March 28, 2022
